Visuals
Sidebar
Possible increase in interval between PCR and antigen testing
Data suggests the interval between initial ability to detect COVID by PCR and later by antigen test has lengthened. Likely ...
U.S. COVID death toll tops 800,000 as Omicron variant makes inroads into Delta’s dominance
“Even if Omicron does cause less severe disease, the sheer number of cases could once again overwhelm unprepared health systems,” ...
Data suggest mixing and matching vaccines enhance immune response against Omicron
Source: Dr. Janine Kimpel and the Medical University of Vienna .
Number of COVID-19 Omicron variant cases in Europe as of November 29, 2021, by country
In late-November 2021, the Omicron variant of SARS-CoV-2 (the virus which causes COVID-19) was designated as a variant of concern ...
The ‘kid effect’ on COVID-19 cases
Projected incident cases modeling outcomes in which new variants do or do not form and in which children are or ...
Global meat supply per capita
Source: UN Food and Agriculture Organization (FAO)
Medicare Advantage marches toward 70% penetration
Medicare Advantage is expected to continue its slow but steady growth, reaching 60% to 70% penetration sometime between 2030 and ...
Full state-by-state guide to vaccine exemptions in the US
Source: National Vaccine Information Center
One in five Americans are unwilling to get vaccinated
A September survey found that nearly one in five Americans are unwilling to get vaccinated. Source: Morning Consult
Association between COVID-19 outcomes and mask mandates, adherence, and attitudes
Using an event study design, authors estimate the treatment effect of the introduction of mask mandates (shown on the vertical ...
Vaccine effectiveness against COVID-19 infections
Differences in the virus, the host, and the study design can affect real-world vaccine effectiveness. CDC uses multiple methods to ...
Lifetime, annual, monthly, and daily prevalence of marijuana use by age.
“The COVID-19 pandemic dramatically changed the way that young people interact with one another and offers us an opportunity to ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more